Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Usability of the FTEXES Wearable Textile Platform for Functional Electrical Stimulation and EMG (FTEXES)

2 novembre 2026 aggiornato da: Giuseppe Andreoni, Politecnico di Milano

Interventional Clinical Trial Evaluating the Usability of the FTEXES System (Functionalized TEXtiles for Electrical Stimulation), a Wearable Textile-Based Platform for Functional Electrical Stimulation and Surface Electromyography

FTEXES (Functionalized TEXtiles for Electrical Stimulation) is a wearable platform based on sensorized garments (Smart Pants and Smart T-shirt) with integrated textile electrodes for surface electromyography (EMG) recording and functional electrical stimulation (FES). This single-center, open-label, non-randomized study evaluates the usability of the system in a controlled laboratory setting. Fifteen participants (5 healthy adults, 5 patients with neuromotor disability, 5 healthcare professionals) take part in a single 45-60 minute session including donning, system setup, calibration, functional tasks (gait for the lower limb; reaching and grasping for the upper limb), doffing and skin inspection. Comfort, skin tolerability, stimulation-related discomfort, perceived usability, satisfaction and acceptability are assessed with standardized questionnaires. The quality of EMG signals recorded with textile electrodes is evaluated as a secondary objective. The study has no therapeutic purpose for individual participants.

Panoramica dello studio

Stato

Non ancora reclutamento

Intervento / Trattamento

Tipo di studio

Interventistico

Iscrizione (Stimato)

15

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Luoghi di studio

    • Lecco
      • Bosisio Parini, Lecco, Italia, 23842
        • IRCCS Eugenio Medea - Associazione La Nostra Famiglia

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

12 anni e precedenti (Bambino, Adulto, Adulto più anziano)

Accetta volontari sani

Sì

Sessi ammissibili allo studio

Tutto

Descrizione

Inclusion Criteria:

  • Healthy adults: age 18 years or older; no neuromotor disability; written informed consent.
  • Patients: age 18 years or older, or 12-17 years with parental/guardian consent and minor's assent; neuromotor disability compatible with the use of the FTEXES system; indication for FES confirmed by a physiatrist. Previous FES experience is not required.
  • Healthcare professionals: professional qualification consistent with study activities (physiotherapist or physiatrist).

Exclusion Criteria:

  • Missing informed consent (for minors: missing parental/guardian consent and/or minor's assent).
  • Inability to understand study aims and procedures or to follow instructions.
  • Clinical, functional, cognitive, behavioral or skin conditions that make participation unsafe or inappropriate, in the investigator's judgment.
  • Skin lesions, abrasions, dermatitis, irritation, infection or other dermatological conditions in device contact areas.
  • Healthy adults: known neuromuscular disease, recent trauma, direct involvement in FTEXES development, or professional/academic dependency on the Principal Investigator.
  • Patients: absence of motor disability compatible with the FTEXES system, or no indication for / unsuitability to FES in the physiatrist's judgment.
  • Healthcare professionals: lack of professional qualification or of competence in the use/configuration of FES systems.
  • Any other condition that, in the investigator's judgment, may interfere with study conduct or endpoint assessment.

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Altro
  • Assegnazione: Non randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Nessuno (etichetta aperta)

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Healthy adults

Five adults aged 18 years or older without neuromotor disability use the FTEXES system in a single session.

Sensorized textile garments (Smart Pants for the lower limb, Smart T-shirt for the upper limb) with integrated textile electrodes, connected to a CE-marked FES stimulator (HASOMED RehaMove3) and a CE-marked surface EMG system (FreeEMG 1000). Single session of about 45-60 minutes: donning, setup, calibration, functional tasks (gait cycle or reaching/grasping), doffing and skin inspection.

Sperimentale: Patients with neuromotor disability

Five patients aged 12 years or older with neuromotor disability compatible with FES, as assessed by a physiatrist, use the FTEXES system in a single session.

Sensorized textile garments (Smart Pants for the lower limb, Smart T-shirt for the upper limb) with integrated textile electrodes, connected to a CE-marked FES stimulator (HASOMED RehaMove3) and a CE-marked surface EMG system (FreeEMG 1000). Single session of about 45-60 minutes: donning, setup, calibration, functional tasks (gait cycle or reaching/grasping), doffing and skin inspection.

Altro: Healthcare professionals

Five healthcare professionals (3 physiotherapists, 2 physiatrists) configure and operate the FTEXES system and evaluate its usability from the operator's perspective.

Sensorized textile garments (Smart Pants for the lower limb, Smart T-shirt for the upper limb) with integrated textile electrodes, connected to a CE-marked FES stimulator (HASOMED RehaMove3) and a CE-marked surface EMG system (FreeEMG 1000). Single session of about 45-60 minutes: donning, setup, calibration, functional tasks (gait cycle or reaching/grasping), doffing and skin inspection.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Perceived usability: System Usability Scale (SUS) score
Lasso di tempo: During and at the end of the single experimental session (approximately 60 minutes)

SUS is a 10-item questionnaire scored from 0 to 100; higher scores indicate better perceived usability.

During and at the end of the single experimental session (approximately 60 minutes)
Wearable comfort: Comfort Rating Scale (CRS) score
Lasso di tempo: During and at the end of the single experimental session (approximately 60 minutes)

Comfort of the textile garments and textile electrodes assessed with the Comfort Rating Scale (CRS); higher scores indicate greater discomfort.

During and at the end of the single experimental session (approximately 60 minutes)
Stimulation-related pain/discomfort (NRS/VAS 0-10)
Lasso di tempo: During and at the end of the single experimental session (approximately 60 minutes)

Global and localized discomfort, perceived fatigue and pain associated with functional electrical stimulation, rated on a 0-10 numeric/visual analogue scale; 0 = none, 10 = worst imaginable.

During and at the end of the single experimental session (approximately 60 minutes)
Satisfaction with the assistive device: adapted QUEST 2.0
Lasso di tempo: During and at the end of the single experimental session (approximately 60 minutes)

Satisfaction with the FTEXES system assessed with an adapted version of the Quebec User Evaluation of Satisfaction with Assistive Technology (QUEST 2.0); items scored 1-5, higher scores indicate greater satisfaction.

During and at the end of the single experimental session (approximately 60 minutes)
Acceptability and intention to use: Net Promoter Score (NPS) and intention-to-use questionnaire
Lasso di tempo: During and at the end of the single experimental session (approximately 60 minutes)

Likelihood to recommend the system (NPS, 0-10 rating, summarized as -100 to +100) and intention to use the platform in the future, including at home.

During and at the end of the single experimental session (approximately 60 minutes)

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Coherence score (0.0-1.0) of EMG signal quality: amplitude and frequency spectrum
Lasso di tempo: During and at the end of the single experimental session (approximately 60 minutes)

Coherence score (0.0 if signal amplitude <50% of amplitude with standard Ag/AgCl electrodes -1.0 = signal amplitude = 100% of amplitude with standard Ag/AgCl electrodes) of Amplitude and frequency spectrum (% coveragle of signal spectrum) of surface EMG signals recorded with the textile electrodes of the FTEXES garments.

During and at the end of the single experimental session (approximately 60 minutes)
FES artifact rejection in EMG signals
Lasso di tempo: During and at the end of the single experimental session (approximately 60 minutes)

Effectiveness of rejection of functional electrical stimulation artifacts in surface EMG signals recorded during stimulation scored as number number of artifacts recorded as number of artifacts out of 10 test events.

During and at the end of the single experimental session (approximately 60 minutes)

Altre misure di risultato

Misura del risultato
Misura Descrizione
Lasso di tempo
Skin tolerability: visual skin inspection
Lasso di tempo: During and at the end of the single experimental session (approximately 60 minutes)

Presence of redness, pressure marks, abrasions or other skin reactions in device contact areas, assessed by visual inspection at the end of the session.

During and at the end of the single experimental session (approximately 60 minutes)
Number of participants with adverse events
Lasso di tempo: During and at the end of the single experimental session (approximately 60 minutes)

Adverse events recorded during the session using the study adverse event form.

During and at the end of the single experimental session (approximately 60 minutes)
Donning and setup performance
Lasso di tempo: During and at the end of the single experimental session (approximately 60 minutes)

Time to don/doff the garments and connect/configure the system, level of assistance required and number of non-critical procedural errors, assessed by observation.

During and at the end of the single experimental session (approximately 60 minutes)

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Collaboratori

Investigatori

  • Investigatore principale: Leonardo Boccuni, PhD, IRCCS Eugenio Medea
  • Cattedra di studio: Giuseppe Andreoni, Politecnico di Milano

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Stimato)

26 ottobre 2026

Completamento primario (Stimato)

30 novembre 2026

Completamento dello studio (Stimato)

31 dicembre 2026

Date di iscrizione allo studio

Primo inviato

22 ottobre 2026

Primo inviato che soddisfa i criteri di controllo qualità

2 novembre 2026

Primo Inserito (Effettivo)

6 novembre 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

6 novembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

2 novembre 2026

Ultimo verificato

1 ottobre 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • 380-26
  • CUP B53C22006960001 (Altro numero di sovvenzione/finanziamento: Italian Ministry of University and Research - PNC Fit4MedRob (PNC0000007))
  • L2-648 (Altro identificatore: Comitato Etico Territoriale Lombardia 2)

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

INDECISO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi